Atlas Trials

Optimal LDL-C Target in High-risk Patients After PCI

Clinical trial NCT06821711 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06821711
Sponsor
Xijing Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Coronary SyndromeAcute Coronary SyndromesPercutaneous Coronary InterventionHigh Risk Patient
Start date
2025-02-20
Primary completion
2029-08-15
Enrollment
12000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.